$192 Million is the total value of Ghost Tree Capital, LLC's 34 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 59.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRput | $29,708,000 | – | 400,000 | +100.0% | 15.47% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWcall | $10,784,000 | – | 400,000 | +100.0% | 5.62% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $10,740,000 | +3.1% | 1,000,000 | -9.1% | 5.59% | +147.4% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $10,175,000 | -19.9% | 225,000 | -10.0% | 5.30% | +92.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $9,745,000 | +149.5% | 130,000 | +160.0% | 5.08% | +498.6% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $8,618,000 | +120.4% | 225,000 | +138.1% | 4.49% | +428.7% |
| COGT | Sell | COGENT BIOSCIENCES INC | $8,118,000 | -36.2% | 900,000 | -47.1% | 4.23% | +53.0% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $7,976,000 | – | 100,000 | +100.0% | 4.15% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $7,384,000 | +349.1% | 110,000 | +450.0% | 3.85% | +977.3% |
| PCVX | Buy | VAXCYTE INC | $7,072,000 | -2.4% | 325,000 | +8.3% | 3.68% | +134.4% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $6,972,000 | -57.6% | 75,000 | -46.4% | 3.63% | +1.8% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $6,942,000 | -19.5% | 600,000 | +28.6% | 3.62% | +93.2% |
| SGEN | New | SEAGEN INC | $6,193,000 | – | 35,000 | +100.0% | 3.23% | – |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $5,693,000 | -25.2% | 45,000 | -25.0% | 2.96% | +79.6% |
| MRUS | Sell | MERUS N V | $5,660,000 | -46.5% | 250,000 | -37.5% | 2.95% | +28.5% |
| ISEE | Buy | IVERIC BIO INC | $4,810,000 | -36.5% | 500,000 | +11.1% | 2.50% | +52.4% |
| CTIC | Sell | CTI BIOPHARMA CORP | $4,776,000 | -21.3% | 800,000 | -38.5% | 2.49% | +88.9% |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $4,748,000 | +75.9% | 250,000 | +150.0% | 2.47% | +322.0% |
| ARVN | ARVINAS INC | $4,630,000 | -37.5% | 110,000 | 0.0% | 2.41% | +50.1% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $4,329,000 | +10.7% | 225,000 | 0.0% | 2.26% | +165.6% | |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $3,850,000 | +19.2% | 275,000 | +37.5% | 2.00% | +186.0% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $3,722,000 | -44.0% | 450,000 | +12.5% | 1.94% | +34.4% |
| XBI | Sell | SPDR SER TRcall | $3,714,000 | -86.2% | 50,000 | -83.3% | 1.93% | -67.0% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,439,000 | -39.6% | 325,000 | -7.1% | 1.79% | +45.0% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $3,011,000 | -45.2% | 165,000 | -34.0% | 1.57% | +31.4% |
| New | DICE THERAPEUTICS INCcall | $2,328,000 | – | 150,000 | +100.0% | 1.21% | – | |
| AADI BIOSCIENCE INC | $1,848,000 | -27.4% | 150,000 | 0.0% | 0.96% | +74.1% | ||
| TARS | TARSUS PHARMACEUTICALS INC | $1,752,000 | -13.2% | 120,000 | 0.0% | 0.91% | +108.4% | |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $1,575,000 | – | 300,000 | +100.0% | 0.82% | – | |
| NMTR | Sell | 9 METERS BIOPHARMA INC | $469,000 | -75.9% | 1,800,000 | -44.6% | 0.24% | -42.3% |
| New | DICE THERAPEUTICS INC | $466,000 | – | 30,000 | +100.0% | 0.24% | – | |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $467,000 | -70.4% | 925,000 | +34.7% | 0.24% | -29.2% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $277,000 | – | 1,900 | +100.0% | 0.14% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -75,000 | -100.0% | -0.07% | – | |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.09% | – |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -85,000 | -100.0% | -0.13% | – | |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -1,315,154 | -100.0% | -0.35% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -993,714 | -100.0% | -0.38% | – |
| STSA | Exit | SATSUMA PHARMACEUTICALS INC | $0 | – | -473,562 | -100.0% | -0.39% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -85,000 | -100.0% | -0.40% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -0.47% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.66% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.69% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -0.80% | – |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -750,000 | -100.0% | -0.81% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -100,000 | -100.0% | -0.95% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCput | $0 | – | -150,000 | -100.0% | -1.35% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -300,000 | -100.0% | -2.22% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -325,000 | -100.0% | -2.26% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -500,000 | -100.0% | -49.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.